Aguilar Tone Hammer 500 Limited Edition Black & Pink Aguilar

Inspired by the journeys and survivors from our team, Aguilar Amplification will join the world in its efforts to raise awareness and funding for breast cancer research during the month of October. With every purchase of this special Tone Hammer 500 proceeds will be donated to The Breast Cancer Research Foundation – a nonprofit organization committed to achieving prevention and a cure for breast cancer. The Tone Hammer 500 Breast Cancer Awareness Edition amplifier will be a limited-run only available during the month of October.

Based on the popular Tone Hammer pedal this superlight bass head combines 3 bands of flexible EQ, a colorful “Drive” control, and 500 watts of power in a 4 lb package. The Tone Hammer 500 will give you the legendary “Aguilar Sound” while still fitting into the accessory pouch of most gig bags – the perfect choice for bass players on the go.
 

Power Output: 500 watts into 4 ohms, 250 watts into 8 ohms
Preamp Section: Solid State
Power Section: Class D
Transformer: Switching mode power supply (SMPS)

EQ Section:
Bass: +/- 17 dB @ 40 Hz
Mid Level: +/- 16 dB
Mid Frequency: 180 Hz – 1 kHz
Treble: +/- 14 dB @ 4 kHz

Drive Control: Fully adjustable, featuring Aguilar’s proprietary AGS(adaptive gain shaping) circuit.
Effects Loop: Series operation. Adds 6 dB of additional gain, making it useful for a broad range of effects units.
Inputs: One 1/4″ input jack, compatible with all active and passive basses
Speaker Outputs: Two Neutrik Speakon speaker outputs
Balanced Output: XLR balanced output with pre/post EQ and ground lift switch
Tuner output
Cooling: Two high quality whisper fans with thermal speed control
Dimensions: 10.75”W X 8.5”D X 2.75”H
Warranty: Three year limited

Breast Cancer Research Foundation
The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. Since its founding in 1993 by Evelyn H. Lauder, BCRF has raised more than a billion dollars to fuel its mission to be the end of breast cancer. Through a unique and streamlined grants program, they seek out the brightest minds in science and medicine and give them the necessary resources to pursue their best ideas. This enables researchers to make discoveries and design new approaches to address all aspects of breast cancer—and do so in record time.